Sleep Disorders Trial, Recruiting NCT06385106 Sponsor: First Affiliated Hospital of Zhejiang University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06385106
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a type of memory problem consistent with Alzheimer's disease (AD), confirmed by memory testing and either a spinal fluid test or a brain scan showing signs of AD.
  • You are between 55 and 80 years old.
  • You do not have significant problems with your vision or hearing.
  • You are right-handed.
  • You are of Han nationality.
  • You are willing and able to sign a consent form agreeing to take part.
  • You have a reliable family member or caregiver who can provide information about you to the research team.
  • Your memory and thinking scores fall within a specific range on standard tests (confirm with trial site for exact scores).
  • If you are already taking an approved Alzheimer's medication (such as donepezil or memantine), your dose has been stable for at least 3 months before joining the trial.

Who may not be able to join:

  • You have a history of seizures or epilepsy.
  • You have had a stroke.
  • You have another brain or nervous system condition, such as Parkinson's disease, schizophrenia, severe depression or anxiety, brain tumors, multiple sclerosis, or a history of significant brain injury.
  • You have serious problems with your liver, kidneys, lungs, heart, blood (such as anemia), or digestive system.
  • You have taken certain sedative or anxiety medications (barbiturates or benzodiazepines) in the past 2 weeks.
  • You have metal implants or other reasons you cannot safely have an MRI scan or a brain stimulation procedure.
  • You have a condition affecting your thinking that is not Alzheimer's disease, such as an underactive thyroid, vitamin deficiencies, infections, or problems with alcohol or drug use.
  • You have significant difficulty speaking, are not fully conscious, or are unable to cooperate with the study tasks.
  • You have previously received certain types of brain stimulation treatments (TMS, tDCS, or DBS).
  • Your memory problems are caused by something other than Alzheimer's disease.
  • A brain scan shows specific types of abnormal changes in your brain unrelated to Alzheimer's disease (confirm with trial site).
  • You are not willing to sign the consent form.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Benyan Luo, PhD, Zhejiang University

Phone: 0571-87235859

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Zhejiang University
Registry
ClinicalTrials.gov
Start date
16 March 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Cognitive funtion; Sleep parameters

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov